Evidence map›Paper›PMID 12542990›Full record

ReviewCurrent allergy and asthma reports2003

Epidemiology of anaphylaxis in the United States.

Matthew J Matasar, Alfred I Neugut

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current allergy and asthma reports, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Outpatient Emergencies: Anaphylaxis.The Medical clinics of North America · 2017
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Food allergy: temporal trends and determinants.Current allergy and asthma reports · 2012
    Review
  9. Neutrophils give us a shock.The Journal of clinical investigation · 2011
    Article
  10. Ingested allergens must be absorbed systemically to induce systemic anaphylaxis.The Journal of allergy and clinical immunology · 2011
    Article
  11. Peanut allergy and anaphylaxis.Current opinion in immunology · 2010
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Matthew J MatasarDepartment of Medicine, New York Presbyterian Hospital, PH 18-127, 630 West 168th Street, New York, NY 10032, USA. ain1@columbia.edu.
Alfred I Neugut
NewYork–Presbyterian Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anaphylaxis is a potentially life-threatening allergic reaction characterized by a syndrome of dermatologic and systemic signs and symptoms, at times including cardiovascular collapse from distributive shock. Although it is recognized that the incidence of anaphylaxis is increasing, the extent of its prevalence, both from individual causes and in toto, remains unclear. Common causes include pharmacologic agents, such as antibiotics and radiocontrast media, as well as foods, insect stings, and latex exposure. The available literature suffers from methodologic shortcomings, limiting the accuracy of estimated prevalence. However, current data suggest that there are approximately 1500 annual deaths from anaphylaxis, and between 2.8 million and 42.7 million Americans are at risk of experiencing an episode of anaphylaxis during their lives.

Indexed as

AnaphylaxisAnimalsDisease SusceptibilityEuropeHumansIncidenceRisk FactorsSyndromeUnited States

Identifiers

PMID12542990
OpenAlexW1996078039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.